| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |